Prognostic Value of Residual Coronary Artery Lesions on the SYNTAX Scale in Patients with Acute Myocardial Infarction without SТ Segment Elevation in the Mid-Term Period

Aim      To study the effect of residual coronary injury after a percutaneous coronary intervention (PCI), as evaluated with the SYNTAX scale (residual SYNTAX score, RSS), on the mid-term prognosis for patients with non-ST elevation acute myocardial infarction (NSTEMI) and also to determine threshold RSS values for patients at high and low risk of adverse cardiac events.

Material and methods  A single-center, retrospective study was performed. From 421 patients with NSTEMI after PCI with stenting, 169 patients were selected who originally had multivessel coronary disease and who had undergone a repeated inpatient examination, including mid-term (11.7±3.0 mos.) coronary angiography. The endpoints were recurrent clinical manifestations of angina, repeat revascularization (RR), unstable angina (UA), recurrent acute myocardial infarction (AMI), cardiac death, and also a composite endpoint (major adverse cardiac events, MACE) that included UA, recurrent AMI, and cardiac death. After revealing a significant direct correlation between RSS and the probability of recurrent AMI, UA, MACE, or RR (p <0.05) using the ROC analysis, we have established threshold RSS values that divided patients into groups with high and low risk of the cardiac events listed above.

Results For a significantly high risk of recurrent AMI (area under the curve, AUC 0.79±0.05; 95 % confidence interval, CI 0.68–0.89; р=0.048), the threshold RSS score was 8 (sensitivity 100 %, specificity 70.9 %). For UA and MACE, the RSS scores were both 3 (AUC 0.68±0.5; 95 % CI 0.58–0.79; p=0.005 and AUC 0.71±0.05; 95 % CI 0.61–0.8; p=0.001, respectively). The probability of UA during the observation period with RSS >3 was 4.07 times higher and that of MACE was 5.23 times higher than with RSS<3 (95 % CI 1.44–11.49; р=0.01 and 95 % CI 1.88–14.53; р=0.001, respectively).

Conclusion      The study demonstrated a significant, direct correlation between the RSS and the risk of adverse cardiac events in patients with NSTEMI during one year of observation. Specific threshold values were obtained, which may help in choosing both the extent of revascularization and the tactics for postoperative management of patients.

1. Belenkov Yu.N., Oganov R.G. Cardiology. National Guidelines: short edition. -M.: GEOTAR-Media;2014. - 848 p. ISBN 978-5-9704-2134-5

2. Tarasov R.S., Ganyukov V.I., Vakkosov K.M., Barbarash O.L., Barbarash L.S. SYNTAX residual in long-term outcomes prognosis of endovascular revascularization in myocardial infarction with ST elevation and multivessel disease. Cardiovascular Therapy and Prevention. 2016;15(5):33–8. DOI: 10.15829/1728-8800-2016-5-33-38

3. Gao G, Dou K, Zhang D. TCT-219 The prognostic value of residual SYNTAX score and its interaction with proximal left anterior descending coronary artery stenosis: Data from 10343 consecutive patients in real world. Journal of the American College of Cardiology. 2017;70(18):B92. DOI: 10.1016/j.jacc.2017.09.296

4. Shakhov E.B., Alekyan B.G. Effectiveness of Incomplete Myocardial Revascularization in Chronic Coronary Occlusions. Modern Technologies in Medicine. 2012;4:43–7.

5. Song Y, Ma Y, Zhang J-H, Tang X-F, Xu J, Yao Y et al. TCT-155 Prognostic Impact of the Residual SYNTAX Score on 2-years Outcomes in Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 2016;68(18):B63–4. DOI: 10.1016/j.jacc.2016.09.297

6. Azzalini L, Ojeda S, Dens J, La Manna A, Benincasa S, Bellini B et al. TCT-302 Impact of incomplete revascularization on longterm outcomes following chronic total occlusion percutaneous coronary intervention. Journal of the American College of Cardiology. 2017;70(18):B124. DOI: 10.1016/j.jacc.2017.09.384

7. Adachi H, Yasuoka Y, Kume K, Hattori S, Noda Y, Araki R et al. The Residual SYNTAX Score for Mortality Risk Assessment in Acute Coronary Syndrome with Cardiogenic Shock. Journal of the American College of Cardiology. 2013;61(10):E20. DOI: 10.1016/S0735-1097(13)60021-2

8. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394

9. Syrkin A.L., Novikova N.A., Terekhin S.A. Acute Coronary Syndrome. -M.: Medical Information Agency;2010. - 440 p. ISBN 978-5-89481-825-2

10. Collet J-P, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2020;32(23):2999–3054. DOI: 10.1093/eurheartj/ehaa575

11. Heitner JF, Senthilkumar A, Harrison JK, Klem I, Sketch MH, Ivanov A et al. Identifying the Infarct-Related Artery in Patients With Non–ST-Segment–Elevation Myocardial Infarction: Insights From Cardiac Magnetic Resonance Imaging. Circulation: Cardiovascular Interventions. 2019;12(5):e007305. DOI: 10.1161/CIRCINTERVENTIONS.118.007305

12. Byuyul’ A., Tsefel’ Р. SРSS: The art of information рrocessing. -M., SPB, Kiev: DiaSoft;2005. - 602 p. ISBN 5-93772-133-0

13. Rafaeli I.R., Kireeva A.Yu., Chernysheva I.E., Kostyanov I.Yu., Tsereteli N.V., Azarov A.V. et al. Terms of admission to the hospital and performing endovascular procedures in patients with acute myocardial infarction without ST segment elevation in real clinical practice. CardioSomatics. 2020;11(3):10–5. DOI: 10.26442/22217185.2020.3.200371

14. Généreux P, Palmerini T, Caixeta A, Rosner G, Green P, Dressler O et al. Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 2012;59(24):2165–74. DOI: 10.1016/j.jacc.2012.03.010

15. Kang J, Han J-K, Kim CH, Kong M-G, Park J, Yang H-M et al. TCT-218 The ‘SYNTAX Score derivatives’ to predict clinical outcomes after percutaneous coronary intervention with Everolimuseluting stents for Left main/three vessel disease patients. Journal of the American College of Cardiology. 2017;70(18):B91–2. DOI: 10.1016/j.jacc.2017.09.295